Evidence map›Paper›PMID 41059020›Full record

ArticleFrontiers in aging neuroscience2025

Regional CSF volume quantification using deep learning for comparative analysis of brain atrophy in frontotemporal dementia subtypes.

Kyoung Yoon Lim, Soyeon Yoon, Seongbeom Park, Seongmi Kim, Kyoungmin Kim, Jehyun Ahn, Jun Pyo Kim, Hee Jin Kim, Duk L Na, Sang Won Seo and 1 more

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kyoung Yoon Lim *BeauBrain Healthcare, Inc., Seoul, Republic of Korea.
Soyeon Yoon *Alzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, Republic of Korea.
Seongbeom ParkBeauBrain Healthcare, Inc., Seoul, Republic of Korea.
Seongmi KimAlzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, Republic of Korea.
Kyoungmin KimAlzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, Republic of Korea.
Jehyun AhnAlzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, Republic of Korea.
Jun Pyo KimAlzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, Republic of Korea.
Hee Jin KimAlzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, Republic of Korea.
Duk L NaDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Sang Won SeoAlzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, Republic of Korea.
Kichang KwakBeauBrain Healthcare, Inc., Seoul, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Frontotemporal dementia (FTD) encompasses heterogeneous clinical syndromes, and distinguishing its subtypes using imaging remains challenging. Methods: We developed a deep learning model to quantify brain atrophy by measuring cerebrospinal fluid (CSF) volumes in key regions of interest (RoIs) on standard MRI scans. In a retrospective study, we analyzed 3D T1-weighted MRI data from 1,854 individuals, including cognitively unimpaired (CU) controls, patients with dementia of the Alzheimer type (DAT), and FTD subtypes: behavioral variant FTD (bvFTD), nonfluent variant primary progressive aphasia (nfvPPA), and semantic variant PPA (svPPA). The model quantified CSF volumes in 14 clinically relevant RoIs and generated age- and sex-adjusted W-scores to express regional atrophy. Results: Each FTD subtype exhibited a distinct, lateralized atrophy pattern: bvFTD showed widespread bilateral frontal and right-predominant parietal and temporal atrophy; nfvPPA showed left-predominant frontal and parietal atrophy; and svPPA exhibited marked left-lateralized temporal and hippocampal atrophy. All FTD subtypes demonstrated significantly greater CSF expansion in these characteristic regions compared to DAT and CU. Discussion: This deep learning approach provides a simple, interpretable measure of brain atrophy that differentiates FTD subtypes, requiring only standard MRI with minimal preprocessing, and offers clinical utility.

Indexed as

brain atrophycerebrospinal fluiddeep learningfrontotemporal dementiamagnetic resonance imaging

Identifiers

PMID41059020
PMCPMC12497847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.